Trial Profile
A Pilot Study in Cancer Patients With Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in the Upper Extremity Treated With Low Molecular Weight Heparin (LMWH) and Apixaban (Catheter 3)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2023
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Low molecular weight heparins
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- Acronyms Catheter 3
- 11 Feb 2021 Planned End Date changed from 31 Dec 2019 to 1 Aug 2021.
- 11 Feb 2021 Planned primary completion date changed from 30 Dec 2019 to 1 Aug 2021.
- 27 Feb 2019 Planned primary completion date changed from 30 Jun 2019 to 30 Dec 2019.